Skip to content
Parakho

Alivus Life Sciences Ltd

NSE ALIVUSBSE 543322alivus.com

Q1 FY27, unaudited

Revenue
₹640.41 Cr
Profit after tax
₹160.08 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations640.41+6.41%2,551.83
Other income22.40+149.32%60.41
Total income662.82+8.51%2,612.24
Employee benefit expense68.25+10.83%272.47
Finance costs1.31+4.48%5.37
Depreciation & amortisation20.59+20.63%75.36
Total expenses450.59+0.61%1,835.28
Profit before tax212.22+30.21%751.31
Tax expense52.15+25.82%186.83
Profit after tax160.08+31.71%564.48
Total comprehensive income160.38+32.30%565.71
Earnings per share
Earnings per share, basic₹13.04₹45.99
Earnings per share, diluted₹13.01₹45.90

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q1 FY27

Alivus Life Sciences reported Q1 FY'27 revenue of INR640 crores, up 6.4% year-on-year, with non-GPL business growing 26.5% while GPL business declined 52.6% due to inventory rationalization. Gross margin improved to 60.2% and EBITDA margin rose to 36.6%, aided by product mix, operational efficiency and forex gains. Management guided to full-year revenue growth of 10% to 12% and EBITDA margins in the 30% to 32% range, with growth skewed toward the second half of the year.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 40 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 25 Aug 2026.